U.S. market Closed. Opens in 53 minutes

TMBR | Timber Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312020-01-312019-01-312018-01-312017-01-312016-01-312015-01-312014-12-31
Revenue83.18K295.74K453.81K324.65K57.00K73.00K100.00K64.00KN/A40.00K
Cost of Revenue13.30M6.15M1.50M3.38M83.00K250.00K516.00K237.00KN/AN/A
Gross Profit-13.22M-5.85M-1.05M-3.06M-26.00K-177.00K-416.00K-173.00KN/A40.00K
Operating Expenses19.24M10.95M18.71M586.72K16.48M16.70M18.01M14.98MN/A7.77M
Selling, General & Admin6.02M5.39M4.06M586.56K7.40M7.56M7.85M9.28MN/A2.95M
Research & Development13.30M6.15M15.10M3.38M9.08M9.14M10.16M5.70MN/A2.52M
Other Operating Expenses-83.18K-590.79K-453.81KN/AN/AN/A0N/AN/A2.30M
Operating Income-19.24M-10.65M-20.21M-3.64M-17.23M-23.94M-18.43M-15.16MN/A-7.77M
Other Expenses / Income-136.45K-19.17K5.13M-156.00-28.00K7.30M22.00K-436.00KN/A-36.00K
Before Tax Income-19.37M-10.67M-15.08M-3.64M-17.26M-16.64M-18.40M-15.59MN/A-7.81M
Income Tax Expenses7.60K-30.24K37.84K-156.002.00K-7.66M2.00K4.00KN/AN/A
Net Income-19.38M-10.64M-15.12M-3.69M-17.26M-8.98M-18.41M-15.60MN/A-7.81M
Interest Expenses228.46K15.55K4.42MN/A28.00K364.00K163.00KN/AN/AN/A
Basic Shares Outstanding2.11M808.81K314.00K125.91K12.88K5.73K2.39K59.83K10.22M10.22M
Diluted Shares Outstanding2.11M808.81K314.00K125.91K12.88K5.73K2.39K59.83K10.22M10.22M
EBITDA-19.16M-10.65M-17.78M-45.56K-17.17M-23.88M-17.98M-15.51MN/A-7.78M
EBITDA Margin-23,032.75%-3,601.23%-3,917.31%-14.03%-30,115.79%-32,717.81%-17,981.00%-24,231.25%0.00%-19,455.00%
EBIT-19.14M-10.65M-10.66M-3.69M-17.23M-16.27M-18.24M-15.59MN/A-7.81M
EBIT Margin-23,015.25%-3,602.46%-2,349.67%-1,136.71%-30,224.56%-22,293.15%-18,241.00%-24,365.63%0.00%-19,517.50%
Financial Year End2022-12-312021-12-312020-12-312020-01-312019-01-312018-01-312017-01-312016-01-312015-01-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙